Baltic private equity house BaltCap has acquired a majority stake in the leading Estonian occupational health care company Qvalitas Arstikeskus AS (Qvalitas). BaltCap Private Equity Fund II (BPEF II) signed an agreement to acquire 72 per cent of Qvalitas. The remaining 28 per cent are held by the management team.
The Standard Life European Private Equity Trust (SLEPET) has reported net asset value (NAV) total return for the six months to 31 March 2016 of 11.3 per cent. NAV total return for the 12 months to 31 March 2016 was 17.4 per cent. The NAV at 31 March 2016 rose
Aleva Neurotherapeutics, a developer of next-generation implants for deep brain stimulation (DBS) in major neurological indications such as Parkinson’s Disease and Essential Tremor, has raised USD 18 million in a Series C financing round. The round was led by Greatbatch (NYSE:GB), a strategic lead investor contributing a total of USD5
Mid-market private equity firm LDC has backed the GBP22m management buyout of global ID cards business, Magicard, from listed defence and security group Ultra Electronics Holdings plc. Founded in 1992, Magicard is one of the world’s leading manufacturers of secure desktop ID card printers, software and related consumables for the
Amulet Capital Partners (Amulet), a middle-market private equity investment firm focused exclusively on the healthcare sector, has acquired SynteractHCR Holdings Corporation (SynteractHCR), a contract research organisation (CRO) focused on Phase I‐IV clinical trials for emerging to mid-sized biopharma clients in the US, Europe and Asia. Terms of the transaction have
State Street Corporation’s (STT) GX Private Equity Index, a benchmark for comparative analysis of private equity performance, which includes a comprehensive data set dating back to 1980, saw an overall return of 1.11 per cent in Q4 2015. “Private equity funds posted a modest recovery in the fourth quarter after
Norsk Titanium AS, a supplier of aerospace-grade, additive manufactured, structural titanium components, has closed a USD10 million growth debt facility with Harbert European Growth Capital Fund I (HEGCF) as part of the company’s current aerospace production financing round. The funds will be used to further strengthen Norsk Titanium’s leadership team
Monroe Capital has acted as co-syndication agent on the funding of a senior credit facility to support Argyle Executive Forum’s (Argyle) acquisition of Innovation Enterprise. Argyle is an existing portfolio company of the Wicks Group. Based in New York City and founded in 2004, Argyle is a provider of high-touch
Lightbend (formerly Typesafe), the company behind the Reactive Platform that includes the Akka, Play and Lagom Frameworks as well as the Scala programming language, has closed a USD20 million Series C funding round led by Intel Capital. Blue Cloud Ventures also joined Intel Capital as a new investor, with full
Global private equity group EQT has held the closing of the EQT Ventures Fund, a multi-stage venture capital fund advised by the EQT Ventures team at EQT Partners (EQT Ventures). The fund will invest in fast-growing, innovative and tech-enabled companies across Europe, supporting great entrepreneurs throughout different stages of growth.
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
